ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

ImmuneOnco Biopharmaceuticals (Shanghai)'s cash flow from discontinued operations for the six months ended in Dec. 2024 was €0.00 Mil. It means ImmuneOnco Biopharmaceuticals (Shanghai) received €0.00 Mil from the sale of part of business quarterly. ImmuneOnco Biopharmaceuticals (Shanghai)'s cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

ImmuneOnco Biopharmaceuticals (Shanghai) Cash Flow from Discontinued Operations Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) Cash Flow from Discontinued Operations Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Cash Flow from Discontinued Operations

ImmuneOnco Biopharmaceuticals (Shanghai) Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial			-	-	-	-	-

ImmuneOnco Biopharmaceuticals (Shanghai) Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

ImmuneOnco Biopharmaceuticals (Shanghai) Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

01541:Hong Kong

Address

1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN

Website

https://cn.immuneonco.com

ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines